| Trial ID: | L4357 |
| Source ID: | NCT02999841
|
| Associated Drug: |
Acarbose
|
| Title: |
Effect of Acarbose and Vildagliptin on Visceral Fat Distribution in Newly Diagnosed Type 2 Diabetes Patients
|
| Acronym: |
VISA-T2DM
|
| Status: |
UNKNOWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2|Obesity
|
| Interventions: |
DRUG: Acarbose|DRUG: Vildagliptin
|
| Outcome Measures: |
Primary: Change of the visceral fat area in square centimeter assessed by abdominal CT scans from baseline to 24 weeks., 24 weeks | Secondary: Change of body weight in kilograms measured by investigators from baseline to 24 weeks., 24 weeks|Change of waist circumstance in centimeters measured by investigators from baseline to 24 weeks., 24 weeks|Change of body mass index in kg/m^2 measured by investigators from baseline to 24 weeks., 24 weeks|Change of the subcutaneous fat area in square centimeters assessed by abdominal CT scans from baseline to 24 weeks., 24 weeks|Change of hemoglobin A1c in percents from baseline to 24 weeks., 24 weeks|Change of hemoglobin fasting plasma glucose in millimols per liter from baseline to 24 weeks., 24 weeks|Change of hemoglobin 2-hour-post-prandial plasma glucose in millimols per liter from baseline to 24 weeks., 24 weeks|Change of triglyceride in millimols per liter from baseline to 24 weeks., 24 weeks|Change of total cholesterol in millimols per liter from baseline to 24 weeks., 24 weeks|Change of low-density lipoprotein-cholesterol in millimols per liter from baseline to 24 weeks., 24 weeks|Change of high-density lipoprotein-cholesterol in millimols per liter from baseline to 24 weeks., 24 weeks|Change of insulin in international units per liter from baseline to 24 weeks., 24 weeks|Change of brain natriuretic peptide in nanograms per milliliter from baseline to 24 weeks., 24 weeks
|
| Sponsor/Collaborators: |
Sponsor: Peking University
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2016-03
|
| Completion Date: |
2018-01
|
| Results First Posted: |
|
| Last Update Posted: |
2016-12-21
|
| Locations: |
Beijing Pinggu Hospital, Beijing, Beijing, 101200, China
|
| URL: |
https://clinicaltrials.gov/show/NCT02999841
|
